Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: "The article doesn't mention costs of angioplasty or costs of medications, which presumably must be taken for the rest of one's life. The article does mention that angioplasty is expensive, but does not provide real numbers or comparisons. The story provides absolute numbers of the primary endpoint over a 4-year period — ""17 percent of those given angioplasty and drugs and nearly 16 percent of those given drugs alone had either died, suffered another heart attack or developed heart failure — results considered to be statistically the same."" The story states that there was a worrisome trend toward more heart attacks in people who received late angioplasty compared to those who received just medications, although the story also tells readers that this could have been a statistical fluke or due to chance. However, other harms of the procedure were not discussed, including risks of the procedure itself, including bleeding, infection, or emotional distress/anxiety. The article also does not discuss risks of the alternative, e.g. medications, which have side effects, costs, or inconvenience. But, the story does discuss the main harm found in the study, e.g. a trend toward increased heart attacks. The research is important because it is a randomized controlled trial and the first such trial to be conducted for the clinical situation of late angioplasty in people with few to no symptoms after their heart attack. The story tells readers that enrollment of patients was delayed because ""doctors were unwilling to risk randomly assigning patients to drug treatment alone,"" indirectly stating that the study was a randomized trial. While an astute reader could probably pick up that this was a randomized trial, this fact could have been clearer. In addition, there is little context around this being the first randomized trial for this clinical situation (as opposed to retrospective observational studies), although the story does tell readers that the results were surprising and that they could change guidelines. The story appropriately describes a heart attack, and more importantly, reinforces that early opening of the artery to restore blood flow to the heart after heart attack is still beneficial and that these results don't apply to that population or indeed the majority of people receiving angioplasties. No obvious disease mongering. The article provides an independent source of information from the chairman of the American Heart Association program committee that reviewed the research. The story also provides information from the director of the National, Heart, Lung, and Blood Institute, but tells readers that this organization largely funded the research, therefore disclosing potential conflicts of interest. The story tells readers that the alternative that was tested in the latest research was medications, including those to lower blood pressure and cholesterol, aspirin, and anti-clotting drugs. The story could have mentioned beta-blockers specifically, since the protective effect of drug treatment may come from this family of drugs, although this is not yet proven. And the story could have been clearer about the course of treatment, e.g. that these medications are generally taken for the rest of one's life. The story tells readers that the usual treatment for people suffering a heart attack is angioplasty, even for a subset of people who weren't treated right away (the study population)/  The article also tells readers that the tendency to perform angioplasty electively (3 to 28 days after the event) was so strong, that recruitment to the study was prolonged in order to find enough patients (and their doctors) willing to participate in the study. It's widely understood that angioplasty and standard drug therapy after heart attack are not new. The article provides independent sources of information not included in the press release."
[A]: Study says late angioplasty futile


[Q]: According to the Maine Center for Disease Control, the number of syphilis cases reported in the state increased from 48 in 2016 to 84 last year. The number of national syphilis cases increased by 18 percent in between 2015 and 2016. Maine Department of Health and Human Services spokeswoman tells the Bangor Daily News the department isn’t sure why syphilis has increased in recent years. Portland Public Health Center medical director Dr. Christina DeMatteo believes opioid use and waning concerns about HIV have contributed to attitudes about having unprotected sex. Public health advocates say budget cuts resulting in changes in prevention and treatment have also affected rates in the state. ___ Information from: Bangor Daily News, http://www.bangordailynews.com
[A]: Maine sees increase in reported syphilis cases.


[Q]: Two Oregon wineries stepped in to buy the grapes, but getting the Oregon Solidarity wines they produced to markets on time is in doubt because the federal agency that approves labels has a huge backlog, a hangover from the government shutdown. Nationwide, makers of alcoholic drinks face disrupted business and lost revenue. If another shutdown starts in about two weeks, as President Donald Trump has threatened if Congress doesn’t provide money for a border wall, the backlog could persist. U.S. Sen. Ron Wyden and U.S. Rep. Earl Blumenauer, both Oregon Democrats, warned of “disastrous” consequences in a letter to John Manfreda, administrator of the U.S. Alcohol and Tobacco Tax and Trade Bureau. They urged Manfreda to dedicate all resources to clearing the backlog of applications. “This regulatory paralysis disproportionately disadvantages small, craft brewers, vintners, cider makers, and distillers, who depend on new product releases for their businesses’ survival,” Wyden and Blumenauer said Tuesday. Michael Kaiser, vice president of WineAmerica, a national association of U.S. wineries, said the backlog will also stretch the turnaround time on new applications to around 36 days. The federal alcohol agency strives for it to be two to four days. It must issue permits for beverages that will be sold across state lines and approve the labels. “This will impact wineries of all size,” Kaiser said in an email. California winery Copper Cane canceled contracts last fall to buy 2,000 tons (1,814 metric tons) of grapes, saying lab testing showed smoke taint after wildfires last year cloaked much of Oregon in smoke and ash. Jim Blumling, Copper Cane’s vice president of operations, has said both lab and sensory tests showed a high level of smoke taint and that the most effective time to test is as close as possible to harvest. But independent laboratory analysis showed much of the crop was not adversely affected, the local wineries said. Willamette Valley Vineyards head winemaker Joe Ibrahim had sampled a few of the grapes, searching for an ashy taste in the skins that would reveal some taint. He found none. “The wines are actually really beautiful wines,” Ibrahim said, standing next to a huge vat in his winery’s cellar containing rose of pinot noir, the first of the three Oregon Solidarity wines that will be bottled. The vineyard outside the small town of Turner and King Estate Winery in Eugene bought 150 tons (136 metric tons) of the grapes, enough to produce 88,800 bottles of wine. Eyrie Vineyards and Silvan Ridge Winery helped make the wines. Willamette Valley and King Estate would have bought even more grapes, but they were already getting overripe on the vine, Willamette winery director Christine Collier Clair said. One grower also had crop insurance for 1,500 tons (1,360 metric tons), she said. The label application for the rose was sent and approved before the government shutdown, Clair said. The federal agency still must approve labels for Oregon Solidarity chardonnay and pinot noir. Retailers are counting on having the wines and to do promotions, she said. The wines will be sold nationwide and will be available to buy online. Rogue Valley Vintners, a southern Oregon nonprofit made up of wine producers, growers and community partners, will get the proceeds. Clair said she hopes the chardonnay label gets approved on time for its scheduled May release. Alcohol and Tobacco Tax and Trade Bureau spokesman Thomas Hogue said there are many applications to wade through. “We are still assessing the workload,” Hogue said in an email Monday, when federal employees returned to work after five weeks. “I think it’s safe to say that our backlog has roughly doubled as a result of the shutdown.” ___ Follow Andrew Selsky on Twitter at https://twitter.com/andrewselsky
[A]:
Shutdown casts pall on effort to help Oregon winegrowers.